Search results
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $21.00 at Barclays
ETF DAILY NEWS· 2 days agoTeva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its price target upped by Barclays from $20.00 to $21.00 in a research note issued to investors on Wednesday ...
Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price Up 4.3%
ETF DAILY NEWS· 6 hours agoJazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) was up 4.3% during trading on Friday . Needham & Company LLC reissued a “buy” rating and issued a $222.00 price objective ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 8 hours agoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering the firm, Marketbeat ...
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Insider Weiss Amir sells 12,635 Shares – Knox Daily
Knox Daily· 4 days agoTeva- Pharmaceutical Industries Ltd. ADR’s recently made public that its Chief Accounting Officer Weiss Amir unloaded Company’s shares for reported $0.21 million on May 16 ...
Steward Partners Investment Advisory LLC Purchases 384 Shares of West Pharmaceutical Services, Inc....
ETF DAILY NEWS· 5 hours agoSteward Partners Investment Advisory LLC raised its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 108.5% in the fourth quarter, HoldingsChannel.com ...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks· 5 days agoTeva Pharmaceutical Industries Limited’s (TEVA Quick QuoteTEVA - Free Report) revenues have suffered...
Vanda Pharmaceuticals stock: why is it up 20% on Thursday?
Invezz· 3 days agoVanda Pharmaceuticals Inc (NASDAQ: VNDA) is up nearly 20% on Thursday following a report that Cycle ...
Celebrity doctors promoted Covid vaccine without declaring payments
The Telegraph via Yahoo News· 20 hours agoThe pharmaceutical watchdog has been urged to investigate after a string of celebrity doctors took...
It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put...
Simply Wall St. via Yahoo Finance· 2 days agoWhile this analysis focuses on total compensation, it's worth acknowledging that the salary portion...
Justin Liby on Pharmaceutical Industry | JD Supra
JD Supra· 3 days agoJD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations. This Privacy Policy describes how JD Supra ...